Safety of immune checkpoint inhibitors analysed

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-018-54274-2
中图分类号
学科分类号
摘要
引用
收藏
页码:11 / 11
相关论文
共 50 条
  • [2] Efficacy and Safety of Immune Checkpoint Inhibitors in Hematologic Malignancies
    Bilgihan, Muhammed Talha
    Eryigit, Ayse Nur
    Ciftciler, Rafiye
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (01): : 23 - 31
  • [3] Safety and efficacy of immune checkpoint inhibitors in elderly patients
    Mailly-Giacchetti, Leah
    Lopez-Trabada, Daniel
    Feldman, Judith
    Andre, Thierry
    Cohen, Romain
    BULLETIN DU CANCER, 2023, 110 (11) : 1204 - 1214
  • [4] Safety of immune checkpoint inhibitors in Chinese patients with melanoma
    Wen, Xizhi
    Wang, Yao
    Ding, Ya
    Li, Dandan
    Li, Jingjing
    Guo, Yiqun
    Peng, Ruiqing
    Zhao, Jingjing
    Zhang, Xing
    Zhang, Xiao-Shi
    MELANOMA RESEARCH, 2016, 26 (03) : 284 - 289
  • [5] Safety of sequential immune checkpoint inhibitors after prior immune therapy
    Awidi, Muhammad
    Connell, Brendan
    Johnson, Delaney
    Craven, Isabel
    Ranjit, Rojer
    Gil, Brigitte
    Dal'Bo, Natalie
    Maher, Lewena
    Daves, Seanna Reilly
    McDonald, Stephanie
    Gunturu, Krishna S.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (06) : 2375 - 2382
  • [6] Safety of sequential immune checkpoint inhibitors after prior immune therapy
    Muhammad Awidi
    Brendan Connell
    Delaney Johnson
    Isabel Craven
    Rojer Ranjit
    Brigitte Gil
    Natalie Dal’Bo
    Lewena Maher
    Seanna Reilly Daves
    Stephanie McDonald
    Krishna S. Gunturu
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 2375 - 2382
  • [7] Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study
    Paderi, Agnese
    Fancelli, Sara
    Caliman, Enrico
    Pillozzi, Serena
    Gambale, Elisabetta
    Mela, Marinella Micol
    Doni, Laura
    Mazzoni, Francesca
    Antonuzzo, Lorenzo
    CURRENT ONCOLOGY, 2021, 28 (05) : 3259 - 3267
  • [8] Immune Checkpoint Inhibitors for Cancer Therapy: Clinical Efficacy and Safety
    Azoury, Said C.
    Straughan, David M.
    Shukla, Vivek
    CURRENT CANCER DRUG TARGETS, 2015, 15 (06) : 452 - 462
  • [9] Safety profile of immune checkpoint inhibitors according to cancer type
    Guerin, Chloe
    Laramas, Mathieu
    Bettega, Francois
    Bocquet, Alexis
    Berton, Elodie
    Lugosi, Maxime
    Bouillet, Laurence
    Toffart, Anne-Claire
    BULLETIN DU CANCER, 2023, 110 (7-8) : 825 - 835
  • [10] Safety and Outcomes of Combining Immune Checkpoint Inhibitors with Radiation Therapy
    Mohamad, O.
    Leiker, A.
    Schroeder, S.
    Zhang, E.
    Trivedi, L.
    Gerber, D.
    Khan, S.
    Iyengar, P.
    Albuquerque, K. V.
    Arriaga, Y.
    Courtney, K.
    Brugarolas, J.
    Hammers, H.
    Timmerman, R. D.
    Hannan, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E610 - E611